Neurocrine Biosciences (NBIX) Tops Q3 EPS by 75c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $159.76 -1.81%
Revenue Growth %: +26.1%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +26.1%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of $0.97, $0.75 better than the analyst estimate of $0.22. Revenue for the quarter came in at $258.5 million versus the consensus estimate of $283.04 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Aspire Biopharma to acquire automotive supplier for $30 million
- UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
